In the News
Cracking the talent shortfall: Strategies for delivering the right talent with an FSP model
Jason Tate lays out multiple approaches to weathering clinical research workforce constraints through the use of FSPs.
Therapeutic Vaccines Development: At the Edge of a New Revolution
Our subject matter experts discuss advances in therapeutic vaccines development for the prevention of infectious diseases.
Use of AUC in AAV Analysis in a GMP Setting
Jie Ding and Jurgen Hannig discuss how to address shortcomings in software that does not comply with GMP standards.
Bridging therapeutic areas in the evolving metabolic space: opportunities, challenges and future perspectives
Graham Ellis, executive senior director, provides an overview of important developments happening in the diabetes/obesity/metabolic space.
Moving the needle on diversity in clinical trials: Where do we go from here?
Rose Blackburne discusses the latest regulatory requirements around diversity in clinical trials, how the industry is responding and what actions will help enable further progress in clinical trial health equity.
PPD/TFS Fostering Global Awareness in Rare Disorders
Galina Nesterova, Executive Medical Director, and Stephen Peroutka, Vice President, discuss the importance of Rare Disease Day and PPD’s commitment to this area.
The Sweet Science of Diabetes Technology
Mona Eskandarian, Director of Project Management, comments on current trends in continuous glucose monitoring technology and the use of eDiaries in diabetes treatment.
PharmaVoice’s crystal ball: What’s next in drug innovation and clinical trials
Les Enterline expects the sourcing of clinical development talent for client engagements to remain highly competitive.
Thermo Fisher’s research business, PPD, to explore effective treatments for ARDS in large trial
The PPD clinical research business has been selected to start a Phase II clinical trial to investigate.
